Serving To Educate Primary Care Clinicians On Metabolic Issues
Evidence Based Medicine Header 1
Medical Education Header 2
Peer-to-peer Exchange Header 3
Metabolic Diseases Header 4
News: Prescriber's Letter August 2016


You'll hear controversy about the efficacy of the intranasal flu vaccine (FluMist)...due to new CDC evidence. 
   It suggests the intranasal vaccine is now only about 3% effective in kids and teens...compared to about 63% with the injectable. 
   This is a surprise. Two years ago, the intranasal vaccine was preferred for most kids ages 2 to 8...since it seemed to work BETTER than the injectable version. 
   Other studies suggest the intranasal form may still be up to 58% effective...and other countries may continue to recommend it this year. 
   No one knows for sure why efficacy varies. One theory is the intranasal form might not work as well after repeat vaccinations. 

 For now, don't plan on giving the intranasal vaccine.

If you would like to access this month's full free article on Vaccines from Prescriber's letter, please click here

Prescriber's Letter offers PCMG Members a 10% discount at two subscription levels:

The Gold Subscription is $129  and includes CME

The Platinum Subscription is $189 and provides enhanced CME and Live Webinar access 

Enter Discount Code PCMG15 when ordering either subscription HERE